Signaling Pathways - MMP - Insulin and Insulin-like Receptors
清除全部
- B4686 TAPI-12 CitationTarget: MMPSummary: TACE/ADAM17抑制剂
- B4664 T-522410 CitationTarget: AP-1|MMPSummary: C-Fos/AP-1抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A4442 WAY 170523Target: MMPSummary: MMP-13抑制剂
- A4432 ARP 1001 CitationTarget: MMPSummary: MMP-2抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A1147 LUTEINIZING HORMONE RELEASING HORMONE HUMANTarget: MMPSummary: 人促黄体激素释放激素乙酸盐(LHRH)
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂